Mr. Frank is a Senior Advisor to PureTech Ventures. He is Vice Chairman of Peter J. Solomon Company, a member of its Mergers and Acquisitions Group, and co-heads PJSC’s global pharmaceutical and life sciences practice.
He was formerly Vice Chairman of Barclays Capital, and previous to that was Vice Chairman and a Director of Lehman Brothers Inc. Before joining Lehman Brothers as a Partner, Mr. Frank was co-director of research, as well as Vice President and Director, of Smith, Barney & Co. Incorporated. He is a Chartered Financial Analyst, a member of The New York Society of Security Analysts and a past president of the Chemical Processing Industry Analysts.
Mr. Frank has provided investment banking services to a host of companies in the pharmaceutical, biotechnology, healthcare service providers, medical device and nutraceutical industries, and has been involved in hundreds of financings and merger and acquisition transactions in the health care field.
He is Chairman of the National Genetics Foundation, a past director of the Salk Institute, a member of the Yale School of Organization and Management Advisory Board, a member of the Pharmaceutical Executive Magazine advisory board, Chairman of the Board of The Irvington Institute for Immunological Research, a member of the Advisory Board of The Harvard School of Public Health and also the John's Hopkin's Bloomberg School of Public Health, and he serves on the Advisory Board of the Massachusetts Institute of Technology Center for Biomedical Innovation.
Mr. Frank was honored for Outstanding Contributions in the Field of Immunology in 1998 by the Irvington Institute for Immunological Research, and, in 1997, he received the Biotech Meeting at Laguna Niguel Hall of Fame Award for Special Recognition for an Individual.
He received The Albert Einstein Award from the Weizmann Institute of Science in 2004, the 2006 Gilda’s Club of New York City Visionary Award and was selected The Top 100 Living Contributors to Biotechnology by Reed Elsevier.